Financhill
Buy
63

CW Quote, Financials, Valuation and Earnings

Last price:
$360.05
Seasonality move :
1.49%
Day range:
$345.84 - $353.80
52-week range:
$250.97 - $393.40
Dividend yield:
0.24%
P/E ratio:
33.20x
P/S ratio:
4.31x
P/B ratio:
5.38x
Volume:
251.9K
Avg. volume:
260.7K
1-year change:
36.31%
Market cap:
$13.2B
Revenue:
$3.1B
EPS (TTM):
$10.55

Earnings Data

Next earnings date for CW
May 07
2025
Most recent earnings per share
$3.09
Beat by $0.00
(Feb 12/2025)
Consensus Estimate
$3.09
(Feb 12/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

CW Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
06/30/2025 Q2 $833.9M -- -- $2.94 --
05/07/2025 Q1 $767.7M -- -- $2.39 --
02/12/2025 Q4 $787M $824.3M $3.09 $3.09 $0.00
10/30/2024 Q3 $757.7M $798.9M $2.89 $2.69 $0.20
08/07/2024 Q2 $735.8M $784.8M $2.58 $2.29 $0.29
05/01/2024 Q1 $664M $713.2M $1.99 $1.72 $0.27
02/14/2024 Q4 $737.1M $785.8M $3.11 $2.92 $0.19
11/01/2023 Q3 $680.4M $724.3M $2.51 $2.38 $0.13
08/02/2023 Q2 $648.5M $704.4M $2.10 $1.98 $0.12
05/03/2023 Q1 $585.5M $630.9M $1.48 $1.40 $0.08
02/21/2023 Q4 -- $757.7M $2.82 -- --
11/02/2022 Q3 -- $630.5M $1.91 -- --
08/03/2022 Q2 -- $609.4M $1.83 -- --
05/04/2022 Q1 -- $559.5M $1.05 -- --
02/23/2022 Q4 -- $661.6M $1.94 -- --
11/03/2021 Q3 -- $620.6M $1.70 -- --
08/04/2021 Q2 -- $621.5M $1.49 -- --
05/05/2021 Q1 -- $597.1M $1.45 -- --
02/24/2021 Q4 -- $668.4M $1.30 -- --
10/28/2020 Q3 -- $571.6M $1.55 -- --
08/03/2020 Q2 -- $550M $0.74 -- --
05/06/2020 Q1 -- $601.2M $1.21 -- --
02/26/2020 Q4 -- $655.8M $2.08 -- --
10/30/2019 Q3 -- $614.9M $1.92 -- --
07/31/2019 Q2 -- $639M $1.86 -- --
05/08/2019 Q1 -- $578.3M $1.29 -- --
02/26/2019 Q4 -- $648.6M $1.89 -- --
10/30/2018 Q3 -- $595.4M $1.68 -- --
07/25/2018 Q2 -- $620.3M $1.68 -- --
05/02/2018 Q1 -- $547.5M $0.98 -- --
02/21/2018 Q4 -- $611.9M $1.52 -- --
10/25/2017 Q3 -- $567.9M $1.43 -- --
07/26/2017 Q2 -- $567.7M $1.13 -- --
05/03/2017 Q1 -- $523.6M $0.73 -- --
02/15/2017 Q4 -- $565.6M $1.53 -- --
10/27/2016 Q3 -- $507.1M $1.02 -- --
07/28/2016 Q2 -- $532.8M $0.88 -- --
05/04/2016 Q1 -- $503.5M $0.73 -- --
02/24/2016 Q4 -- $588.8M $1.51 -- --
10/28/2015 Q3 -- $525.5M $0.71 -- --
07/29/2015 Q2 -- $545.2M $0.53 -- --

Curtiss-Wright Earnings Questions

  • How Much did Curtiss-Wright Generate in Revenue Last Quarter?

    Curtiss-Wright reported $824.3M worth of top line sales in its most recent quarter.

  • Did Curtiss-Wright Beat Earnings Last Quarter?

    Curtiss-Wright announced earnings per share of $3.09 which represents a beat of analyst forecast a $3.09 per share.

  • Is Curtiss-Wright Profitable?

    Curtiss-Wright reported $317.4M that represents $8.32 per share over the last quarter.

  • What is the Analyst Consensus for Curtiss-Wright EPS Next Year?

    Curtiss-Wright's earnings are forecast to grow from $10.55 per share to $10.73 per share next year representing an increase of 15.95%.

  • When is Curtiss-Wright's Earnings Date?

    Curtiss-Wright's next earnings date is May 7, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Palantir Stock a Millionaire Maker?
Is Palantir Stock a Millionaire Maker?

Palantir (NASDAQ:PLTR) has shot upward over the last year and…

Is QuantumScape a Buy Now?
Is QuantumScape a Buy Now?

QuantumScape (NYSE:QS) is an innovative EV battery company that specializes…

Is Vertex Stock Still a Good Buy?
Is Vertex Stock Still a Good Buy?

Over the past ten years or so, Vertex Pharmaceuticals (NASDAQ:…

Stock Ideas

Sell
50
Is AAPL Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 35x

Buy
68
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 36x

Buy
59
Is NVDA Stock a Buy?

Market Cap: $2.7T
P/E Ratio: 38x

Alerts

Buy
62
RGC alert for May 2

Regencell Bioscience Holdings [RGC] is down 16.88% over the past day.

Buy
65
MYRG alert for May 2

MYR Group [MYRG] is up 1.9% over the past day.

Sell
35
FTAI alert for May 2

FTAI Aviation [FTAI] is up 6.92% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock